,physiology,nursing,NCLEX,health,disease,biology,medicine,nurse education,medical education,pathophysiology,campbell,human biology,human body,7jpNld_XEko,UCF9IOB2TExg3QIBupFtBDxg, Politics,Society, channel_UCF9IOB2TExg3QIBupFtBDxg, video_7jpNld_XEko,Mr. Russell Broadbent, MP
https://russellbroadbent.com.au
Letter to Anthony Albanese, Australian Prime Minister
https://russellbroadbent.com.au/australiansdemandanswers/
Mr Broadbent on X, https://twitter.com/BroadbentMP
Great discussion with Mr. Russell Broadbent MP. A politician who advocates for and correctly represents his constituents and the wider world. Thank you.
… our fathers brought forth on this continent, a new nation, conceived in Liberty, and dedicated to the proposition that all men are created equal.
… and that government of the people, by the people, for the people, shall not perish from the earth.
Abraham Lincoln
November 19, 1863
The Hon Anthony Albanese MP Prime Minister
Parliament House
CANBERRA ACT 2600
By email: parliament@pm.gov.au Dear Prime Minister
I refer to my letter of 20 September 2024 calling on the government to immediately suspend the use of Pfizer and Moderna Covid-19 products due to the evidence of significant synthetic DNA contamination, as detailed in Dr. David Speicher’s report.
Unlike the Thalidomide tragedy, which resulted in over 10,000 victims globally, the Covid-19 vaccines have been administered to more than 20 million Australians, totalling over 63 million doses. The contamination detected in these vaccines, if not addressed, presents a substantial risk, with the potential for these dangers - such as genomic integration and potential long-term health impacts - to multiply with each additional dose administered. Immediate action through a suspension of these products is critical to mitigate further risk.
To assist in adopting a precautionary approach and minimizing further harm, I enclose a Science Summary created and endorsed by eminent Australian and international scientists and medical experts. The summary reinforces the known and potential dangers of DNA contamination and highlights the need for an urgent and independent investigation. As advised by the co-signatories, the Department of Health and Aged Care has produced no evidence to demonstrate why the detected DNA contamination will not produce the dire adverse health outcomes detailed in the Science Summary.
Additionally, I have reason to believe that multiple attempts by prominent scientists to warn the TGA of these risks have been disregarded since early 2021, raising serious questions about the agency's ability to protect the health and well-being of Australians.
Finally, I draw your attention to the Biosecurity Act 2015, which may now be relevant. Given the contamination evidence, I recommend the Minister for Agriculture initiate a Biosecurity Import Risk Analysis of these products, potentially leading to the suspension of these products due to the risks they pose to human health.
I gratefully acknowledge the assistance of the 52 co-signatories below in the preparation of this letter and reiterate my call seeking your urgent action to ensure the safety of all Australians.
Yours sincerely
Russell Broadbent MP Member for Monash
,physiology,nursing,NCLEX,health,disease,biology,medicine,nurse education,medical education,pathophysiology,campbell,human biology,human body,1AHJc8D-7Vg,UCF9IOB2TExg3QIBupFtBDxg, Health,Knowledge, channel_UCF9IOB2TExg3QIBupFtBDxg, video_1AHJc8D-7Vg,Turbo cancers are rapidly forming, spreading and mutating.
UK surgeon, Dr James Royle
Confirming Prof. Angus Dalgleish
‘Many of my multidisciplinary team colleagues, fellow surgeons, oncologists, pathologists, radiologists and specialist nurses all acknowledged to me sudden change in patterns,
and dramatic increase in these incurable advanced cancers that we’ve observed in these past two years.’
The close temporal association between the increase cancers and the rollout fulfils the gold standard Bradford-Hill epidemiological criteria for causation.
Dr. James Royle
https://odysee.com/@HealthandTruth:8/Stone-Summit-Stormont-Belfast-Session-4:d
Jerry Quinn
https://odysee.com/@HealthandTruth:8/Stone-Summit-Stormont-Belfast-Session-5-With-Gerry-Quinn:d
Dr. Elizabeth Evens
https://odysee.com/@HealthandTruth:8/Stone-Summit---Stormont,-Belfast---Session-2-with-Dr.-Elizabeth-Evans:4
Dr. Clare Craig
https://odysee.com/@HealthandTruth:8/Stone-Summit-Stormont-Belfast-Session-6-With-Dr-Clare-Craig:0
Dr. Johathan Engler
https://www.youtube.com/watch?v=63qeqLA9V9Q
Dr. Ros Jones
https://www.youtube.com/watch?v=u2IvS6KSo9I
https://odysee.com/@HealthandTruth:8/Stone-Summit---Stormont,-Belfast---Session-3-with-Dr.-Ros-Jones-1080:1
,physiology,nursing,NCLEX,health,disease,biology,medicine,nurse education,medical education,pathophysiology,campbell,human biology,human body,aURT9LLiz2M,, Health,Knowledge, channel_UCF9IOB2TExg3QIBupFtBDxg, video_aURT9LLiz2M,Intradermal Mycobacterium vaccae and obuense (IMM-101)
Oral Non-typeable Haemophilus influenzae (NTHi)
UK could be first country to offer norovirus jab against ‘winter vomiting bug’
New vaccine could stop people developing the highly infectious illness after early trial results found it creates a ‘strong immune response’
https://www.telegraph.co.uk/news/2024/10/23/norovirus-vaccine-winter-vomiting-bug-moderna-wes-streeting/
mRNA
Systemic distribution inevitable
Antigenic dose produced varies
Longevity of mRNA?
Use of synthetic base
Contamination from manufacturing process
https://www.nihr.ac.uk/news/uks-first-norovirus-mrna-vaccine-trial-launched
First Phase 3 randomised clinical trial
Nova 301 trial, mRNA-1403
Trivalent, targeting three major strains of norovirus
mRNA norovirus vaccine, UK wide, 39 sites
Sponsored by Moderna,
Trial evaluates the efficacy and safety of mRNA-1403
Aims to recruit 2,500 participants, UK, late October to early 2025
Some mobile sites for community visits
25,000 globally
Half mRNA, half placebo
18 years + but 60 + wanted
Single dose vaccine at the first visit - a jab given in the upper arm.
The trial lasts up to 25 months.
At least six in-person visits to the clinical trial site,
and five phone calls with the trial team.
Part of a 10-year partnership between Moderna and the UK Health Security Agency (UKHSA) on behalf of UK Government
https://www.gov.uk/government/news/uk-cements-10-year-partnership-with-moderna-in-major-boost-for-vaccines-and-research
UK Vaccine Innovation Pathway (VIP) and the NIHR working together to accelerate vaccine trials in the UK.
https://bepartofresearch.nihr.ac.uk/?utm_source=nihr-website&utm_medium=referral&utm_campaign=bpor-nova
Dr Patrick Moore, Chief Investigator of the trial
The UK is really pleased to be able to play an important role in helping find an effective vaccine against this highly contagious disease.
NIHR Chief Executive Professor Lucy Chappell
Leveraging the UK’s expertise in vaccine development, the DHSC through the NIHR and Moderna are delivering this large-scale trial at pace,
so that people across the UK and the world can benefit sooner.
From the NIHR site
the Nova 301 trial serves as a model for future collaborations between the public and private sectors in advancing medical research.
Norovirus
https://www.cdc.gov/norovirus/data-research/index.html#:~:text=Economic%20impact,-Norovirus%20illness%20is&text=Every%20year%2C%20norovirus%20is%20estimated,healthcare%20costs%20and%20lost%20productivity.
https://emedicine.medscape.com/article/224225-overview
Worldwide, about 1 out of every 5 cases of acute gastroenteritis is caused by norovirus.
Gastroenteritis typically develops 12-48 hours after ingestion of contaminated food or water or after contact with an infected individual.
Symptoms typically last for 24-72 hours.
All ages
Nausea and vomiting
Watery diarrhea
Possible dehydration
Abdominal cramps
Headaches
Low-grade fever
Myalgias and malaise
Norovirus genus
More than 40 different strains
GII.4 Sydney
Transmission
Person to person, direct contact, exposure to aerosols, fecal–oral routes.
ID50 = 10 virions
,physiology,nursing,NCLEX,health,disease,biology,medicine,nurse education,medical education,pathophysiology,campbell,human biology,human body,ENuGXJB06o0,, Health,Society, channel_UCF9IOB2TExg3QIBupFtBDxg, video_ENuGXJB06o0,Vitamin D: A key player in COVID‐19 immunity and lessons from the pandemic to combat immune‐evasive variants
https://link.springer.com/article/10.1007/s10787-024-01578-w
As of July 2024
775,754,322 confirmed cases of COVID-19
13,578,710,228 vaccine doses had been administered
It is unclear why some patients develop severe symptoms while others do not,
literature suggests a role for vitamin D.
Vitamin D plays a crucial role in the infection or in ameliorating the severity of symptoms.
VDD is associated with increased hospitalization of severely ill patients and increased levels of COVID-19-caused mortality.
The mechanism of action of vitamin D and vitamin D deficiency (VDD) is well understood.
Vitamin D levels and genetic variations in the vitamin D receptor (VDR) gene significantly impact the severity and out- comes of COVID-19,
especially in the infections caused by Delta and Omicron variants.
Furthermore, VDD causes immune system dysregulation upon infection with SARS-CoV-2,
indicating that vitamin D sufficiency is crucial in fighting against COVID-19 infection.
Potential role as a prophylactic and treatment adjunct.
Immunomodulatory and anti-inflammatory effects of vitamin D
Ability to enhance the efficacy of new antiviral drugs
Large- scale randomized trials are required to reach a definitive conclusion.
Mechanisms of action
Macrophages activated to produce defensive proteins and stimulate naïve T cells
Activate T lymphocytes and mature B lymphocytes into plasma cells
Prevents inflammation, vasoconstriction, and fibrosis of the lungs.
Prevents excess release of cytokines from macrophages
Prevents excessive CRP production in the liver
Vit D can reduce viral replication
Vitamin D can protect against ARDS, the main death-causing complication of COVID-19
Seven out of nine studies reviewed by Yisak
https://pubmed.ncbi.nlm.nih.gov/33447107/
have indicated a crucial role in vitamin D status in COVID-19 infection, prognosis, and mortality.
Vitamin D dose
To decrease the risk of contracting a new infection,
people at high risk of COVID-19 to take 10,000 IU d−1 of vitamin D for a few weeks,
followed by 5000 IU d−1 to raise the concentrations of the active form of vitamin D.
Blood levels
Levels below 12 ng/mL indicate severe deficiency.
Levels between 12 and 20 ng/mL suggest deficiency
Treatment recommended for levels below 30 ng/mL
Optimal levels are 30–60 ng/mL,
Recommended prophylactic dose
0–1 years, 400 IU/day (10 mcg)
over 1 year, 600 IU (15 mcg)
over 8 years, half an adult dose
Adults, 800– 2000 IU of cholecalciferol
Routine toxicity monitoring is unnecessary for doses under 10,000 IU/day
,1,Isle of Wight mushroom farm, https://www.iwmushrooms.co.uk/
Thanks to Alex and Dana for showing us around and teaching us about functional mushrooms.